semaglutide adverse events Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Once-Weekly Semaglutide in Adolescents with

The Juventas Wellness team of board-certified internal medicine physicians brings years of experience and a deep commitment to your well-being

Most people get through their first week without major issues

Whole-grain foods are important sources of micronutrients and dietary fiber, the Obesity study authors note

6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive results from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in 263 adults with obesity or overweight with at least one obesity-related comorbidity and without type 2 diabetes

Chemical peels for maintenance 3

Abstract The integrity of cellular membranes is critical for the functionality of axons